Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of peripheral blood DNA methylation level with Alzheimer's disease progression. | Clin Epigenetics | 2021 | 34654479 | PubTator, text mining | PubMed |
| Endurance exercise training-responsive miR-19b-3p improves skeletal muscle glucose metabolism. | Nat Commun | 2021 | 34642330 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. | Int J Mol Sci | 2021 | 34638971 | PubTator, text mining | PubMed |
| Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. | Cancers (Basel) | 2021 | 34638293 | PubTator, text mining | PubMed |
| Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer. | Cancers (Basel) | 2021 | 34638242 | PubTator, text mining | PubMed |
| Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells. | Bioengineered | 2021 | 34637670 | PubTator, text mining | PubMed |
| Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis. | BMC Genom Data | 2021 | 34635059 | PubTator, text mining | PubMed |
| Long non-coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA-204-5p/SEMA4B axis. | Oncol Lett | 2021 | 34630709 | PubTator, text mining | PubMed |
| miR-515-5p inhibits the proliferation, migration and invasion of human breast cancer cells by targeting CBX4. | Exp Ther Med | 2021 | 34630682 | PubTator, text mining | PubMed |
| [Expression of MicroRNAs in Peripheral Blood of Patients with Primary Immune Thrombocytopenia and Its Correlation with the Imbalance of Th1/Th2 Cell]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 | 34627442 | PubTator, text mining | PubMed |
| Targeting microRNAs with thymoquinone: a new approach for cancer therapy. | Cell Mol Biol Lett | 2021 | 34627167 | PubTator, text mining | PubMed |
| The Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review. | Front Aging Neurosci | 2021 | 34621163 | PubTator, text mining | PubMed |
| Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection. | BMC Genomics | 2021 | 34620091 | PubTator, text mining | PubMed |
| circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p. | Open Med (Wars) | 2021 | 34616917 | PubTator, text mining | PubMed |
| Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases. | J Inflamm Res | 2021 | 34616171 | PubTator, text mining | PubMed |
| Construction of a ceRNA network in glioma and analysis of its clinical significance. | BMC Genomics | 2021 | 34615480 | PubTator, text mining | PubMed |
| Biological functions and clinical significance of long noncoding RNAs in bladder cancer. | Cell Death Discov | 2021 | 34611133 | PubTator, text mining | PubMed |
| Potential Role of Exercise Induced Extracellular Vesicles in Prostate Cancer Suppression. | Front Oncol | 2021 | 34595123 | PubTator, text mining | PubMed |
| Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. | Mol Ther Oncolytics | 2021 | 34589581 | PubTator, text mining | PubMed |
| Effect of freeze-thawing process on lipid peroxidation, miRNAs, ion channels, apoptosis and global DNA methylation in ram spermatozoa. | Reprod Fertil Dev | 2021 | 34585662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=60